Evidence for and consequences of chronic heme deficiency in Belgrade rat reticulocytes

Biochim Biophys Acta. 1999 Mar 8;1449(2):125-36. doi: 10.1016/s0167-4889(99)00006-3.

Abstract

The Belgrade rat has a microcytic, hypochromic anemia inherited as an autosomal recessive trait (gene symbol b). Transferrin-dependent iron uptake is defective because of a mutation in Nramp2 (now DMT1, also called DCT1), the protein responsible for endosomal iron efflux. Hence, Belgrade reticulocytes are iron deficient. We show that a chromatographic method is able to measure the amount of 'free' heme in reticulocytes. Most of the 'free' heme is the result of biosynthesis. Succinylacetone, an inhibitor of heme synthesis, decreases the level of 'free' heme and cycloheximide, an inhibitor of globin synthesis, increases the 'free' heme level. In a pulse-chase experiment with 59Fe-transferrin, the 'free' heme pool behaves as an intermediate, with a half-life of just over 2 h. Belgrade reticulocytes contain about 40% as much 'free' heme as do heterozygous or homozygous reticulocytes. This deficiency of 'free' heme slows initiation of translation in Belgrade reticulocytes by increasing the level of an inhibitor of initiation. Thus the Belgrade rat makes a whole animal model available with chronic heme deficiency.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anemia, Hypochromic / blood
  • Anemia, Hypochromic / genetics*
  • Animals
  • Cell-Free System
  • Cycloheximide / pharmacology
  • Disease Models, Animal
  • Heme / biosynthesis
  • Heme / deficiency*
  • Heptanoates / pharmacology
  • Iron / metabolism
  • Rats
  • Reticulocytes / drug effects
  • Reticulocytes / metabolism*

Substances

  • Heptanoates
  • Heme
  • succinylacetone
  • Cycloheximide
  • Iron